The global transcutaneous neurostimulator market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising geriatric population. The global transcutaneous neurostimulator market is segmented on the basis of type, application, and region. On the basis of type, it can be classified into sacral nerves, vagus nerves, and brain. On the basis of application, it can be classified into Alzheimer's disease (AD), gastroparesis (GP), incontinence (I), Parkinson's disease (PD). North America dominates this market with a share of over 40%. Europe follows North America with a share close to 30%. Asia Pacific has been witnessing significant growth in recent years due to increasing awareness about chronic diseases in developing countries such as India and China.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic pain conditions such as arthritis, cancer, and diabetes are driving the growth of the Transcutaneous Neurostimulator market.
- Increasing number of patients suffering from chronic pain conditions is also driving the growth of the Transcutaneous Neurostimulator market.
- The increasing number of clinical trials for new drugs and therapies in this field is also driving the growth of this market.
- The increasing adoption rate for TENS devices by physicians and healthcare providers is also contributing to the growth in this market.
Industry Growth Insights published a new data on “Transcutaneous Neurostimulator Market”. The research report is titled “Transcutaneous Neurostimulator Market research by Types (Sacral Nerves, Vagus Nerves, Brain, Others), By Applications (Alzheimer's Disease, Gastroparesis, Incontinence, Parkinson's Disease, Others), By Players/Companies Medtronic, Apnex Medical, BioMedical Life Systems, Boston Scientific Corporation, Cochlear LTD, DJO, Dynatronics Corporation, EnteroMedics, MED-EL Corporation, St. Jude Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transcutaneous Neurostimulator Market Research Report
By Type
Sacral Nerves, Vagus Nerves, Brain, Others
By Application
Alzheimer's Disease, Gastroparesis, Incontinence, Parkinson's Disease, Others
By Companies
Medtronic, Apnex Medical, BioMedical Life Systems, Boston Scientific Corporation, Cochlear LTD, DJO, Dynatronics Corporation, EnteroMedics, MED-EL Corporation, St. Jude Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Transcutaneous Neurostimulator Market Report Segments:
The global Transcutaneous Neurostimulator market is segmented on the basis of:
Types
Sacral Nerves, Vagus Nerves, Brain, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Alzheimer's Disease, Gastroparesis, Incontinence, Parkinson's Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Apnex Medical
- BioMedical Life Systems
- Boston Scientific Corporation
- Cochlear LTD
- DJO
- Dynatronics Corporation
- EnteroMedics
- MED-EL Corporation
- St. Jude Medical
Highlights of The Transcutaneous Neurostimulator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sacral Nerves
- Vagus Nerves
- Brain
- Others
- By Application:
- Alzheimer's Disease
- Gastroparesis
- Incontinence
- Parkinson's Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transcutaneous Neurostimulator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A transcutaneous neurostimulator (TCN) is a medical device that uses electrical stimulation to treat conditions such as chronic pain, depression, and anxiety. TCNs are placed on the skin over the body where they deliver electrical current to specific areas of the brain.
Some of the major players in the transcutaneous neurostimulator market are Medtronic, Apnex Medical, BioMedical Life Systems, Boston Scientific Corporation, Cochlear LTD, DJO, Dynatronics Corporation, EnteroMedics, MED-EL Corporation, St. Jude Medical.
The transcutaneous neurostimulator market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transcutaneous Neurostimulator Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transcutaneous Neurostimulator Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transcutaneous Neurostimulator Market - Supply Chain
4.5. Global Transcutaneous Neurostimulator Market Forecast
4.5.1. Transcutaneous Neurostimulator Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transcutaneous Neurostimulator Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transcutaneous Neurostimulator Market Absolute $ Opportunity
5. Global Transcutaneous Neurostimulator Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transcutaneous Neurostimulator Market Size and Volume Forecast by Type
5.3.1. Sacral Nerves
5.3.2. Vagus Nerves
5.3.3. Brain
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transcutaneous Neurostimulator Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transcutaneous Neurostimulator Market Size and Volume Forecast by Application
6.3.1. Alzheimer's Disease
6.3.2. Gastroparesis
6.3.3. Incontinence
6.3.4. Parkinson's Disease
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transcutaneous Neurostimulator Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transcutaneous Neurostimulator Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transcutaneous Neurostimulator Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transcutaneous Neurostimulator Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transcutaneous Neurostimulator Demand Share Forecast, 2019-2026
9. North America Transcutaneous Neurostimulator Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transcutaneous Neurostimulator Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transcutaneous Neurostimulator Market Size and Volume Forecast by Application
9.4.1. Alzheimer's Disease
9.4.2. Gastroparesis
9.4.3. Incontinence
9.4.4. Parkinson's Disease
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transcutaneous Neurostimulator Market Size and Volume Forecast by Type
9.7.1. Sacral Nerves
9.7.2. Vagus Nerves
9.7.3. Brain
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transcutaneous Neurostimulator Demand Share Forecast, 2019-2026
10. Latin America Transcutaneous Neurostimulator Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transcutaneous Neurostimulator Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transcutaneous Neurostimulator Market Size and Volume Forecast by Application
10.4.1. Alzheimer's Disease
10.4.2. Gastroparesis
10.4.3. Incontinence
10.4.4. Parkinson's Disease
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transcutaneous Neurostimulator Market Size and Volume Forecast by Type
10.7.1. Sacral Nerves
10.7.2. Vagus Nerves
10.7.3. Brain
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transcutaneous Neurostimulator Demand Share Forecast, 2019-2026
11. Europe Transcutaneous Neurostimulator Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transcutaneous Neurostimulator Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transcutaneous Neurostimulator Market Size and Volume Forecast by Application
11.4.1. Alzheimer's Disease
11.4.2. Gastroparesis
11.4.3. Incontinence
11.4.4. Parkinson's Disease
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transcutaneous Neurostimulator Market Size and Volume Forecast by Type
11.7.1. Sacral Nerves
11.7.2. Vagus Nerves
11.7.3. Brain
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transcutaneous Neurostimulator Demand Share, 2019-2026
12. Asia Pacific Transcutaneous Neurostimulator Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transcutaneous Neurostimulator Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transcutaneous Neurostimulator Market Size and Volume Forecast by Application
12.4.1. Alzheimer's Disease
12.4.2. Gastroparesis
12.4.3. Incontinence
12.4.4. Parkinson's Disease
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transcutaneous Neurostimulator Market Size and Volume Forecast by Type
12.7.1. Sacral Nerves
12.7.2. Vagus Nerves
12.7.3. Brain
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transcutaneous Neurostimulator Demand Share, 2019-2026
13. Middle East & Africa Transcutaneous Neurostimulator Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transcutaneous Neurostimulator Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transcutaneous Neurostimulator Market Size and Volume Forecast by Application
13.4.1. Alzheimer's Disease
13.4.2. Gastroparesis
13.4.3. Incontinence
13.4.4. Parkinson's Disease
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transcutaneous Neurostimulator Market Size and Volume Forecast by Type
13.7.1. Sacral Nerves
13.7.2. Vagus Nerves
13.7.3. Brain
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transcutaneous Neurostimulator Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transcutaneous Neurostimulator Market: Market Share Analysis
14.2. Transcutaneous Neurostimulator Distributors and Customers
14.3. Transcutaneous Neurostimulator Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Apnex Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BioMedical Life Systems
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boston Scientific Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cochlear LTD
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. DJO
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dynatronics Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. EnteroMedics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. MED-EL Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. St. Jude Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook